Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy in Supraspinatus Tendinitis

Not Applicable

• Conditions: Supraspinatus Tendinitis

• Registration Number: NCT05192746
• Lead Sponsor: Cairo University

Brief Summary

Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon)

Detailed Description

Shock wave therapy is an effective method of dissolving calcification and stimulating tissue healing. Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.US have been widely used for more than 40 years in the treatment of musculoskeletal disorders such as tendinitis, tenosynovitis, epicondylitis, bursitis and osteoarthritis. High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon) "the intensity of ultrasound is first increased to the threshold pain level (to 1.5 W/cm) and then reduced to one half of that intensity. It was kept at that level for 4 to 5 seconds and then reduced to the half-intensity level for another 15 seconds .

Study Timeline

• Study First Submitted: 2021-10-27
• Status Verified: 2021-12
• Study Start: 2022-01
• Study First Submitted QC: 2022-01-01
• Last Update Submitted: 2022-01-01
• Study First Posted: 2022-01-14
• Last Update Posted: 2022-01-14
• Primary Completion: 2022-10
• Study Completion: 2022-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

• Patients' age ranges from 30 to 50 years old.
• Patients are males and females.
• BMI of all subjects were <30 Kg/m2.
• Patients will be diagnosed as supraspinatus tendinitis.
• All patients are medically stable.
• All patients should be conscious and ambulant.
• Patients don't have any nervous system problems
• Patients don't have shoulder disorder other than tendenities
• Patients that didn't undergo any surgery in shoulder joint

Exclusion Criteria

• • Patients who received intra articular injection from duration less than 3 months.

  • Patients with supraspinatus tendonitis secondary to trauma.
  • Patients with metal implants.
  • Patient who had malignancy in the affected area.
  • Patient with acute infection in the treated area.
  • Diabetic patients
  • Bone infection
  • Shoulder instability
  • Epilepsy
  • Coagulation diseases
  • Rheumatological diseases (rheumatoid arthritis and gouty arthritis)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
1. pain intensity[Time Frame:]	up to four weeks	pain will be measured by visual analogue scale higher score mean worse outcome ten centimeter line from zero to ten, zero mean no pain and ten mean maximum pain
2.range of motion	up to four weeks	range of motion will be measured by gravititional inclinometer